Myelodysplastic Syndromes: Updates and Nuances. - Wikidata - awgldk - TriplyDB

Myelodysplastic Syndromes: Updates and Nuances.

Myelodysplastic Syndromes: Updates and Nuances.

http://www.wikidata.org/entity/Q38965973

about

Myelodysplastic Syndromes: Updates and Nuances.

http://www.wikidata.org/entity/Q38965973

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Myelodysplastic Syndromes: Updates and Nuances.

@en

type

label

Myelodysplastic Syndromes: Updates and Nuances.

@en

prefLabel

Myelodysplastic Syndromes: Updates and Nuances.

@en

P1433

Q38965973-6A5DFF2F-8272-45D3-88B2-F39A038F996D

P1476

Q38965973-F5EB8979-B74F-40BB-AB6E-A80FD2166E73

P2093

Q38965973-5698921F-E772-4F9F-A642-65EDA6B564A0

P2860

Q38965973-02AACDBA-9DD9-4FEC-B7CF-4A05FC17B2B8

Q38965973-032CD3F1-D0F4-472F-B5A4-E7A4809953E4

Q38965973-04B1853E-9C68-40AC-80AC-1C609141C388

Q38965973-055BEC9A-4B0E-40A5-8B18-53D979ABCA7E

Q38965973-057DCFF9-BE49-4597-9228-01BDE8D10010

Q38965973-06E32C84-1D72-44FE-8BDB-0666B822AB81

Q38965973-0D10A7D4-DF6A-431C-88D7-3B2F86EDD292

Q38965973-143099F6-791F-4284-809C-211554AAFE1D

Q38965973-1479AC80-4BB7-47E2-9440-EEE7F80EA089

Q38965973-1795AF86-20D8-4B9D-8C1B-2794CFE23E4A

P304

Q38965973-A71F5D39-581D-448B-827C-F3DFF4F43BB2

P31

Q38965973-C54EC876-AFB4-46C4-B3D3-789FFF16A697

P356

Q38965973-5EAB88AC-59D0-404F-BADB-114A71319F89

P433

Q38965973-966A6122-91F5-4382-AB88-760F1CB3D637

P478

Q38965973-9B17CC00-DD64-41FE-973B-829360E84571

P577

Q38965973-1B7E5C86-D664-4E11-BDE4-F9461718CB95

P698

Q38965973-847A93EB-545A-4360-A13F-1CA526297A0A

P932

Q38965973-EC8028B9-6A37-4E77-B28F-834CE096ABC4

P356

J.MCNA.2016.09.006

P1433

Medical Clinics of North America

P1476

Myelodysplastic Syndromes: Updates and Nuances.

@en

P2093

Kim-Hien T Dao

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Epidemiology of myelodysplastic syndromes

DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.

Hematopoietic cell transplantation for myelodysplastic syndrome

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

International scoring system for evaluating prognosis in myelodysplastic syndromes

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis

P304

333-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MCNA.2016.09.006

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28189174

http://www.w3.org/2001/XMLSchema#string

P932

5358800

http://www.w3.org/2001/XMLSchema#string